Cure Research for Diabetic neuropathy
Research discussion: Researchers are exploring treatment with a compound called myoinositol. Early findings have shown that nerves in diabetic animals and humans have less than normal amounts of this substance. Myoinositol supplements increase the levels of this substance in tissues of diabetic animals, but research is still needed to show any concrete lasting benefits from this treatment.
Another area of research concerns the drug aminoguanidine. In animals, this drug blocks cross-linking of proteins that occurs more quickly than normal in tissues exposed to high levels of glucose. Early clinical tests are under way to determine the effects of aminoguanidine in humans.
One approach that appeared promising involved the use of aldose reductase inhibitors (ARIs). ARIs are a class of drugs that block the formation of the sugar alcohol sorbitol, which is thought to damage nerves. Scientists hoped these drugs would prevent and might even repair nerve damage. But so far, clinical trials have shown that these drugs have major side effects and, consequently, they are not available for clinical use. 1
Participants in the DCCT were examined to detect the development of nerve damage (diabetic neuropathy). Study results showed the risk of nerve damage was reduced by 60 percent in persons on intensive treatment.2
Medical research for Diabetic neuropathy: medical news summaries: The following medical news items are relevant to medical research for Diabetic neuropathy:
- Diabetic neuropathic pain alleviated with common nutrient
- New drug approved for treatment of pain associated with diabetic neuropathy
1. excerpt from Diabetic Neuropathy The Nerve Damage of Diabetes: NIDDK
2. excerpt from Diabetes Control and Complications Trial (DCCT): NIDDK
Medical Tools & Articles:
- Risk Factor Center
- Medical Statistics Center
- Medical Treatment Center
- Prevention Center
- Medical Tests Center